Therapeutic Drug Monitoring During Pregnancy and Lactation: Thyroid Function Assessment in Pregnancy—Challenges and Solutions
- 1 June 2010
- journal article
- conference paper
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 32 (3) , 265-268
Abstract
The diagnosis and monitoring of thyroid disease necessitates the knowledge of thyroid pathophysiology and of the technical limitations of current thyroid-related biochemical tests. Thyroid disease diagnosis and monitoring are further complicated during pregnancy and lactation, due to pregnancy-related changes in thyroid hormone metabolism. Dramatic changes that occur in thyroxine and triiodothyronine ranges during pregnancy pose challenges for hypothyroid gravidas. Very early in pregnancy, levothyroxine replacement needs to be increased. Moreover, increases in thyroid hormone replacement need to be conducted individually and on a timely basis. For reasons that are still not entirely clear, although dependent in part on changes in thyroxine binding, free thyroxine (FT4) levels decrease as pregnancy progresses necessitating the use of trimester-specific reference intervals for appropriate replacement. Thyroxine binding protein levels vary by hormonal status, inheritance, and disease states and are higher in pregnancy; hence, FT4 assays became popular because they measure the unbound hormone. However, current FT4 immunoassays are estimate tests that do not reliably measure FT4 and are known to be sensitive to alterations in binding proteins and therefore are method-specific. The need to reliably identify hypothyroxinemic pregnant patients, especially in the first trimester, is of prime importance for early fetal brain development before the fetal thyroid functions. This article addresses 1) the current limitations of laboratory-free thyroxine immunoassay methodologies and especially during pregnancy; 2) trimester-specific reference intervals for thyroid function tests; and 3) the study of levothyroxine pharmacokinetics in pregnant and nonpregnant women.Keywords
This publication has 31 references indexed in Scilit:
- Defining the Roles of the Iodothyronine Deiodinases: Current Concepts and ChallengesEndocrinology, 2009
- First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium studyAmerican Journal of Obstetrics and Gynecology, 2008
- Gestation-Specific Thyroxine and Thyroid Stimulating Hormone Levels in the United States and WorldwideTherapeutic Drug Monitoring, 2007
- A Direct Free Thyroxine (T4) Immunoassay with the Characteristics of a Total T4 ImmunoassayClinical Chemistry, 2007
- Tandem Mass Spectrometry Improves the Accuracy of Free Thyroxine Measurements During PregnancyThyroid®, 2007
- Trimester-specific reference intervals for thyroxine and triiodothyronine in pregnancy in iodine-sufficient women using isotope dilution tandem mass spectrometry and immunoassaysClinica Chimica Acta, 2004
- Increased TBG During Pregnancy and Increased Hormonal RequirementsThyroid®, 2004
- Clinical Evaluation of Nine Free Thyroxine Assays: Persistent Problems in Particular PopulationsClinical Chemistry and Laboratory Medicine (CCLM), 2003
- Maternal Thyroid Deficiency during Pregnancy and Subsequent Neuropsychological Development of the ChildNew England Journal of Medicine, 1999
- Thyroid Development and Disorders of Thyroid Function in the NewbornNew England Journal of Medicine, 1981